The epidemiology of polymyalgia rheumatica in primary care: a research protocol

BMC Musculoskeletal Disorders

Christian D Mallen⁴  Irena Zwierska⁴  Simon Wathall⁴  Edward Roddy⁴  Charlotte Purcell⁴  Zoe Mayson⁴  Rhian Hughes⁴  Rebecca Foskett¹  Bhaskar Dasgupta³  Louise Cope⁴  Kevin Barraclough²  Joanne Bailey⁴  Toby Helliwell⁴  Samantha Hider⁴  Sara Muller⁴ 

[1] Primary Care Research West Midlands North, Unit 2, Badhan Court, Telford, TF1 5QX, UK;Painswick Surgery, Hoyland House, Painswick, Gloucestershire, GL6 6RD, UK;Southend University Hospital, Southend University Hospital NHS Foundation Trust, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 ORY, UK;Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele, Staffordshire, ST5 5BG, UK

关键词: Medical records;    Health surveys;    Cohort studies;    Primary health care;    Polymyalgia rheumatica;   

Others  :  1149417
DOI  :  10.1186/1471-2474-13-102

 received in 2012-05-08, accepted in 2012-06-15,  发布年份 2012

【 摘 要 】

Background

Polymyalgia Rheumatica (PMR) is the commonest inflammatory condition seen in older patients in primary care. To date, however, research has been focused on secondary care cohorts rather than primary care where many patients are exclusively managed. This two year prospective inception cohort study of PMR patients will enable us to understand the full spectrum of this condition.

Methods

Patients diagnosed with PMR in primary care will be identified via Read codes and mailed a series of postal questionnaires over a two-year period to assess their levels of pain, stiffness and functioning, as well as medication usage and other health-related and socio-demographic characteristics. In addition, participants will be asked for permission to link their survey data to their general practice electronic medical record and to national mortality and cancer registers.

Discussion

This will be the first large-scale, prospective, observational cohort of PMR patients in primary care. The combination of survey data with medical records and national registers will allow for a full investigation of the natural history and prognosis of this condition in the primary care setting, in which the majority of patients are treated, but where little research on the treatment and outcome of consultation has been undertaken. This will provide information that may lead to improved primary care management of PMR.

【 授权许可】

   
2012 Muller et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J, Hollywood J, Hutchings A, Kyle V, Nott J, Power M, Samanta A, BSR and BHPR Standards Guidelines and Audit Working Group, BSR and BHPR Standards Guidelines and Audit Working Group: BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 2010, 49:186-190.
• [2]Cimmino MA, Zaccaria A: Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 2000, 18(Suppl 20):S9-S11.
• [3]Smeeth L, Cook C, Hall AJ: Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 2006, 65:1093-1098.
• [4]Kyle V, Silverman B, Silman A, King H, Oswalkd N, Reiss B, Hazelman B: Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice. Br Med J 1985, 291:385-387.
• [5]Barraclough K, Liddell WG, du Toit J, Foy C, Dasgupta B, Thomas M, Hamilton W: Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome. Fam Pract 2008, 25:328-333.
• [6]Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM, Hunder GG, Therneau TM, Gabriel SE: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011, 63:633-639.
• [7]Chuang TY, Hunder GG, Ilstrup DM, Kurland LT: Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680.
• [8]Doran ME, Crowson CS, O’Fallon MW, Hunder GG, Gabriel SE: Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County Minnesota, USA. J Rheumatol 2002, 29:1694-1697.
• [9]Christensen K, Doblhammer G, Rau R, Vaupel JW: Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
• [10]Chakravarty K, Elgabani SHS, Scott DGI, Merry P: A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1994, 33:152-156.
• [11]Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, Maradit-Kremers H, Hutchings A, Matteson EL, Schirmer M, International Work Group for PMR and GCA, International Work Group for PMR and GCA: Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis 2011, 70:447-753.
• [12]Schaufelberger C, Bengtsson BA, Andersson R: Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995, 34:261-264.
• [13]Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT: Causes of death in polymyalgia rheumatica: A prospective longitudinal study of 315 cases and matched controls. Scand J Rheumatol 2003, 32:38-41.
• [14]Royal College of Physicians: Diagnosis and management of polymyalgia rheumatica. [http://www.rcplondon.ac.uk/sites/default/files/polymyalgia-rheumatica-concise-guideline.pdf webcite]
• [15]Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, et al.: 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012, 71:484-492.
• [16]The EuroQol Group: EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
• [17]Pincus T, Summey JA, Sorcai SA, Wallston KA, Hummon NP: Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthrtis Rheum 1983, 26:1346-1353.
• [18]Kerwan JR, Reeback JS: Stanford Health Assessment Questionnaire Modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986, 25:206-209.
• [19]Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System. J Pain Symptom Manage 1997, 13:63-74.
• [20]Morin CM: Insomnia: psychological assessment and management. Guilford Press, New York; 1993.
• [21]Spitzer RL, Kroenke K, Williams JB, Löwe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166:1092-1097.
• [22]Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH: The PHQ-8 as a measure of current depression in the general population. J Affective Disorders 2009, 114:163-173.
• [23]Office for National Statistics: Standard Occupational Classification 2010 (SOC2010). [http://www.ons.gov.uk/about-statistics/classifications/current/soc2010/index.html webcite]
• [24]Haywood KL, Garratt AM, Jordan KP, Healey EL, Packham JC: Evaluation of ankylosing spondylitis quality of life (EASi-QoL): reliability and validity of a new patient-reported outcome measure. J Rheumatol 2010, 37:2100-2109.
• [25]Krumholz HM, Butler J, Miller J, Vaccarino V, Williams CS, de Leon CF Mendes, Seeman TE, Kasl SV, Berkman LF: Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998, 97:958-964.
• [26]Birrell F, Croft P, Cooper C, Hosie G, Macfarlane GJ, Silman A, PCR Hip Study Group, PCR Hip Study Group: Radiographic change is common in new presenters in primary care with hip pain. Rheumatology (Oxford) 2000, 39:772-775.
• [27]Jordan K, Clarke AM, Symmons DP, Fleming D, Porcheret M, Kadam UT, Croft P: Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br J Gen Pract 2007, 57:7-14.
• [28]Dunn KM, Jordan K, Croft PR: Characterizing the course of low back pain: a latent class analysis. Am J Epidemiol 2006, 163:754-761.
• [29]Mallen CD, Peat G, Thomas E, Wathall S, Whitehurst T, Clements C, Bailey J, Gray J, Croft PR: The assessment of the prognosis of musculoskeletal conditions in older adults presenting to general practice: a research protocol. BMC Musculoskelet Disord 2006, 7:84. BioMed Central Full Text